Provided by Tiger Trade Technology Pte. Ltd.

Sionna Therapeutics

5.10
-0.1600-3.04%
Pre-market: 5.140.0400+0.78%08:15 EDT
Volume:1.06M
Turnover:5.40M
Market Cap:229.49M
PE:-2.35
High:5.33
Open:5.26
Low:5.03
Close:5.26
52wk High:54.97
52wk Low:4.01
Shares:45.00M
Float Shares:16.73M
Volume Ratio:0.98
T/O Rate:6.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1683
EPS(LYR):-1.8835
ROE:-32.34%
ROA:-21.54%
PB:0.86
PE(LYR):-2.71

Loading ...

Is Sionna Therapeutics (SION) Stock Overvalued After Its Strong 1 Year Run And 6x P/B Multiple

Simply Wall St.
·
May 05

Sionna Therapeutics initiated with an Outperform at Wedbush

TIPRANKS
·
May 05

Sionna Therapeutics Is Maintained at Buy by Jones Trading

Dow Jones
·
Apr 29

Sionna Therapeutics price target raised to $63 from $52 at JonesResearch

TIPRANKS
·
Apr 28

Sionna Therapeutics announces annual shareholder meeting

Reuters
·
Apr 28

Sionna Therapeutics Price Target Maintained With a $58.00/Share by BTIG

Dow Jones
·
Apr 28

Sionna Therapeutics completes enrollment in Phase 2a PreciSION CF trial of SION-719

Reuters
·
Apr 27

Sionna Therapeutics Inc: Anticipates Data From Precision CF Trial in Summer of 2026.

THOMSON REUTERS
·
Apr 27

Sionna Therapeutics Completes Enrollment in Precision CF Phase 2a Trial Evaluating Nbd1 Stabilizer, Sion-719, Added to Standard of Care in Participants With Cystic Fibrosis

THOMSON REUTERS
·
Apr 27

Sionna director Peter A. Thompson disposes of USD 2.5 million common shares

Reuters
·
Apr 22

OrbiMed Advisors reports Sionna Therapeutics common stock disposal worth $2.5 million

Reuters
·
Apr 22

Sionna director Peter A. Thompson disposes of common shares worth $23.2 million

Reuters
·
Apr 17

OrbiMed Advisors reports Sionna Therapeutics common stock disposal worth $23.1 million

Reuters
·
Apr 17

Assessing Sionna Therapeutics (SION) Valuation After Recent Trading And Cystic Fibrosis Pipeline Expectations

Simply Wall St.
·
Apr 10

Sionna Therapeutics to attend Raymond James Biotech Innovation Symposium investor meetings

Reuters
·
Apr 07

Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium

GlobeNewswire
·
Apr 07